N-Acetyl Selank Amidate: research, legal status and who sells it
This page is information, not medical advice. N-Acetyl Selank Amidate is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- NA-Selank, N-Acetyl Selank
- Category
- Modified selank (N-terminally acetylated, C-terminally amidated) sold by research-peptide vendors
- Price range
- $1.52/mg to $7.50/mg, median $4.00/mg across 14 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains N-acetyl selank amidate [1]. |
| United Kingdom | No UK-licensed medicine containing N-acetyl selank amidate appears in the MHRA products database [2]. |
| European Union | No medicine containing N-acetyl selank amidate is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing N-acetyl selank amidate appears in Health Canada's Drug Product Database [5]. |
| Australia | N-acetyl selank amidate is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7]. |
We haven't published a full overview of N-Acetyl Selank Amidate yet. The legal status table and live prices on this page are current.
N-Acetyl Selank Amidate prices: cheapest listings
The five lowest $/mg listings out of 17. See all N-Acetyl Selank Amidate prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Nexaph | 45 | 10 mg × 10 | $152 | $1.52/mg | View | ||
| Peptides World | 80 | 30 mg | $64 | $2.13/mg | View | ||
| Peptide Partners FDA warning letter, Aug 2026 | 55 | NA Selank Amidate (30mg vials) | 30 mg × 20 | $1,380 | $2.30/mg | Out of stock | View |
| Peptide Partners FDA warning letter, Aug 2026 | 55 | NA Selank Amidate (30mg vials) | 30 mg × 10 | $840 | $2.80/mg | Out of stock | View |
| Peptide Partners FDA warning letter, Aug 2026 | 55 | NA Selank Amidate (30mg vials) | 30 mg × 5 | $495 | $3.30/mg | Out of stock | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "selank". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026